Excilor Fungal Nail Treatment

Detail

Product description

Excilor® Fungal Nail Infection is a clinically proven, topical treatment for fungal nail infections. Penetrates the nail without filing and acts fast to block the progression of the fungal nail infection. Helps to rebuild the damaged nail structure, improving the cosmetic aspect of the nail and providing a barrier against fungal nail infections. Nails grow back healthier and stronger so re-contamination is being prevented.

  • Effective treatment
  • Visible results after 2 weeks
  • Easy to use
  • 1 minute a day, no filing needed

Instructions

  • Clean the nail and if wearing nail varnish remove completely before using Excilor®.
  • Use the brush to coat the complete nail and underneath the nail rim with the product. Make sure you apply Excilor® generously twice a day (once in the morning and once in the evening). For the best results treat the infected area for a minimum of 3 months. It is recommended to continue treatment until the healthy nail has re-grown.
  • Allow the nail to dry (1 to 2 minutes) before putting on socks and/or shoes.
  • Regularly cut your nails.

Precautions

  • For external use only
  • Do not use if you are hypersensitive or allergic to any of the ingredients
  • Avoid all contact with eyes and mucous membranes
  • If the product comes into contact with eyes or mucous membranes rinse with plenty of water
  • No clinical data available on the use of the product by children during pregnancy or breastfeeding women
  • Diabetics with foot problems should consult their doctor when starting to use Excilor®
  • Do not use the product after its expiry date

Ingredients
Ethyl lactate, acetic acid, penetration enhancer, film-forming agent, water, glycerol, polysorbate 80, cetyl acetate, acetylated lanolin alcohols, biotin and preservative (contains no parabens)

Ref Description Options
UXCLS00 Solution 3.3ml Each

In order to view prices and purchase from Trycare, you must register as a user or log in if you are already registered with us.

Recently Viewed